0001145549-22-015850.txt : 20220314 0001145549-22-015850.hdr.sgml : 20220314 20220314151341 ACCESSION NUMBER: 0001145549-22-015850 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220314 DATE AS OF CHANGE: 20220314 EFFECTIVENESS DATE: 20220314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Manager Directed Portfolios CENTRAL INDEX KEY: 0001359057 IRS NUMBER: 571138125 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-21897 FILM NUMBER: 22736305 BUSINESS ADDRESS: STREET 1: C/O U.S. BANCORP FUND SERVICES, LLC STREET 2: 615 E. MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 9522306140 MAIL ADDRESS: STREET 1: C/O U.S. BANCORP FUND SERVICES, LLC STREET 2: 615 E. MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 FORMER COMPANY: FORMER CONFORMED NAME: Roxbury Funds DATE OF NAME CHANGE: 20060411 0001359057 S000012813 Hood River Small-Cap Growth Fund C000034642 Institutional Shares HRSMX C000160233 Investor Shares HRSRX C000179260 Retirement Shares HRSIX 0001359057 S000055882 Pemberwick Fund C000176027 Pemberwick Fund Shares 0001359057 S000059043 Vert Global Sustainable Real Estate Fund C000193646 Institutional Shares VGSRX 0001359057 S000060175 Spyglass Growth Fund C000196940 Institutional Shares SPYGX C000196941 Retail Shares 0001359057 S000061218 Hardman Johnston International Growth Fund C000198300 Institutional Shares HJIGX C000198301 Retail Shares HJIRX 0001359057 S000061322 Dakota Emerging Markets Fund C000198526 Institutional Shares C000198527 Retail Shares 0001359057 S000063161 Argent Small Cap Fund C000204775 Institutional Shares ACMSX C000204776 Retail Shares 0001359057 S000063189 iM Dolan McEniry Corporate Bond Fund C000204812 Advisor Shares IDMAX C000204813 Institutional Shares IDMIX 0001359057 S000064047 iM DBi Managed Futures Strategy ETF C000207161 iM DBi Managed Futures Strategy ETF DBMF 0001359057 S000066474 iM DBi Hedge Strategy ETF C000214391 iM DBi Hedge Strategy ETF DBEH 0001359057 S000073660 Hood River International Opportunity Fund C000230725 Retirement Shares HRITX C000230726 Institutional Shares HRIOX C000230727 Investor Shares 0001359057 S000073733 Sphere 500 Fossil Free Fund C000230850 Sphere 500 Fossil Free Fund SPFFX 0001359057 S000074750 Greenspring Income Opportunities Fund C000232912 Retail Shares C000232913 Institutional Shares GRIOX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001359057 XXXXXXXX false false false N-1A true Manager Directed Portfolios 811-21897 0001359057 549300J0JL5T81OQ6O93 615 E. Michigan Street Milwaukee 53202 US-WI US 2626821135 U.S. Bank N.A. 1555 North River Center Drive Suite 302 Milwaukee 53212 8336121912 Custody Records N N N N-1A 9 Y Scott Craven Jones N/A N Gaylord Brickwood Lyman Jr. N/A N Lawrence T. Greenberg N/A N James Robert Schoenike 001041981 N Justin Dausch N/A 223 Wilmington West Chester Pike Suite 216 Chadds Ford 19317 XXXXXX N N N N N N Quasar Distributors LLC 8-52323 000103848 N/A N ALPS Distributors, Inc. 8-34626 000016853 N/A N N BBD LLP 00552 N/A N N N N N N N Argent Small Cap Fund S000063161 549300R68Q3CKSOCOT61 N 2 0 0 N/A N N Y N N/A N/A N/A N/A Y Y Y N Argent Capital Management LLC 801-55903 000107930 N/A N U.S. Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4O33MV32P92 N N U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N Jones Trading Institutional Services LLC 8-26089 000006888 2138008JJ5PA8H5UIL69 7638.780000000000 Instinet LLC 8-23669 000007897 549300MGMN3RKMU8FT57 5352.600000000000 Northcoast Research Partners, LLC 8-68115 000149109 2549006Z9URN8P891M84 4535.400000000000 Truist Securities, Inc. 8-17212 000006271 CSVTK36R0PNGXEM7NS14 4185.000000000000 21711.780000000000 U.S. Bancorp Investments, Inc. 8-35359 000017868 H85Z6XZP8B10ES0M2G89 22774865.560000000000 22774865.560000000000 N 26470310.000000000000 N N N Spyglass Growth Fund S000060175 549300VSBO6U4TKNS090 N 2 0 0 N/A Y N Y N N/A N/A N/A N/A Y Y Y N Spyglass Capital Management LLC 801-112070 000281266 254900IFBWVZ8D9XH541 N U.S. Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4O33MV32P92 N N U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N U.S. Bancorp Fund Services LLC N1GZ7BBF3NP8GI976H15 N N N Williams Trading LLC 8-50372 000043678 254900XH331390J1WT63 1222715.170000000000 Cowen & Company, LLC 8-22522 000007616 549300WR155U7DVMIW58 94485.440000000000 1317200.610000000000 0.000000000000 N 2320336209.000000000000 N N N true INTERNAL CONTROL RPT 2 argent123121n-cen.htm ARGENT AUDIT OPINION

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

To the Board of Trustees of Manager Directed Portfolios 

and the Shareholders of Argent Small Cap Fund 

  

  

In planning and performing our audit of the financial statements of Argent Small Cap Fund, a series of shares of beneficial interest in Manager Directed Portfolios (the “Fund”), as of December 31, 2021, and for the year then ended, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting.  Accordingly, we express no such opinion. 

  

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America (“GAAP”).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.  

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness, as defined above, as of December 31, 2021.  

  

This report is intended solely for the information and use of management and the shareholders of Argent Small Cap Fund, the Board of Trustees of Manager Directed Portfolios and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ BBD, LLP 

  

BBD, LLP 

  

  

Philadelphia, Pennsylvania 

February 28, 2022 

  

INTERNAL CONTROL RPT 3 spyglass123121n-cen.htm SPYGLASS AUDIT OPINION

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

To the Board of Trustees of Manager Directed Portfolios 

and the Shareholders of Spyglass Growth Fund 

  

  

In planning and performing our audit of the financial statements of Spyglass Growth Fund, a series of shares of beneficial interest in Manager Directed Portfolios (the “Fund”), as of December 31, 2021, and for the year then ended, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting.  Accordingly, we express no such opinion. 

  

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America (“GAAP”).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.  

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness, as defined above, as of December 31, 2021.  

  

This report is intended solely for the information and use of management and the shareholders of Spyglass Growth Fund, the Board of Trustees of Manager Directed Portfolios and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

/s/ BBD, LLP 

  

BBD, LLP 

  

  

Philadelphia, Pennsylvania 

February 28, 2022